News

The Chronic Obstructive Pulmonary Disease Foundation, or COPD, has stepped forward to help Ena Respiratory, an Australian clinical-stage pharma company, to develop an antiviral nasal spray targeting chronic lung disease patients. Ena is getting ready to conduct phase 2...

Varicose veins are swollen, twisted veins that bulge on the surface of the skin. Many adults in America have them and it is treated as a common condition around the world. Several experts and research institutions often consider them as...

Varicose veins are a common problem among adults in America. In fact, approximately 24% of adults living in America have visible varicose veins. With that, many patients are now turning to surgeons and vein specialists to have them removed. There...

It's no secret that pharmaceutical companies have been criticised for their unequal access to COVID-19 vaccines. Oxfam has won several battles to obtain pricing and intellectual property information from Johnson & Johnson, Pfizer, and Moderna. Shareholders of J&J will have an...

Singapore is the first country in WHO's categorization of regulatory authority for medical goods to obtain the highest maturity level (ML 4) out of 28 nations formally examined. With ML 4, Singapore is one step closer to being a...

In the fight against COVID-19, the world may soon have another vaccine choice. A positive result from late-stage clinical testing of a novel vaccine that will be called Vidprevtyn has been announced by Sanofi and GSK by the formers...

On the opening day of the 19th edition of BioAsia, a special fireside chat between Dr. Sangita Reddy, MD, of Apollo Hospitals and Dr. Drew Weissman, the pioneer who has brought mRNA tech to vaccines, spotlighted a revolutionary revelation...